14.96
price up icon4.62%   0.66
 
loading
Schlusskurs vom Vortag:
$14.30
Offen:
$14.43
24-Stunden-Volumen:
362.39K
Relative Volume:
0.76
Marktkapitalisierung:
$648.61M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+19.39%
1M Leistung:
-16.38%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$13.96
$15.06
1-Wochen-Bereich:
Value
$12.26
$15.06
52-Wochen-Spanne:
Value
$8.89
$24.36

Beta Bionics Inc Stock (BBNX) Company Profile

Name
Firmenname
Beta Bionics Inc
Name
Telefon
949-427-7785
Name
Adresse
11 HUGHES, IRVINE
Name
Mitarbeiter
354
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-25
Name
Neueste SEC-Einreichungen
Name
BBNX's Discussions on Twitter

Vergleichen Sie BBNX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
BBNX
Beta Bionics Inc
14.96 543.25M 0 0 0 0.00
Medical Devices icon
ABT
Abbott Laboratories
125.73 228.77B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.16 153.09B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
395.15 149.27B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.65 114.31B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.30 45.06B 5.54B 4.18B 623.10M 7.00

Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-16 Eingeleitet Truist Buy
2025-06-12 Eingeleitet Lake Street Buy
2025-05-30 Eingeleitet Goldman Neutral
2025-05-30 Eingeleitet Wolfe Research Outperform
2025-02-24 Eingeleitet BofA Securities Buy
2025-02-24 Eingeleitet Lake Street Buy
2025-02-24 Eingeleitet Leerink Partners Outperform
2025-02-24 Eingeleitet Piper Sandler Overweight
2025-02-24 Eingeleitet Stifel Buy
2025-02-20 Eingeleitet Ladenburg Thalmann Neutral
2025-02-20 Eingeleitet Robert W. Baird Neutral
Alle ansehen

Beta Bionics Inc Aktie (BBNX) Neueste Nachrichten

pulisher
02:24 AM

What analysts say about Beta Bionics Inc. stockMassive wealth growth - jammulinksnews.com

02:24 AM
pulisher
Jul 22, 2025

Beta Bionics Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Beta Bionics Inc. stock priceBreakthrough financial growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Beta Bionics, Inc.’s Lock-Up Period Will Expire on July 29th (NASDAQ:BBNX) - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

Is Beta Bionics Inc. a good long term investmentConsistent triple-digit returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 20, 2025

Is Sprinklr Inc. a good long term investmentConsistent triple returns - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

Editas Medicine Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

NIP Group Inc. Depositary Receipt Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Investing in IT Sector Top Investment Strategy ToolsExplosive trading opportunities - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

SKF India Limited (SKFINDIA) Stock RalliesFree Trend-Following Techniques - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Best Indian Stocks for Stable Returns Professional Trading PicksFree Predictions - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 16, 2025

Beta Bionics (BBNX) Drops 2.15% Despite Abbott Partnership - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Why Beta Bionics Inc. stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Beta Bionics Inc. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Beta Bionics Inc. stock price move sharplyLow Risk Scalping Alerts - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Abbott, Beta Bionics Partner to Integrate Dual Glucose-Ketone Sensor with iLet Bionic Pancreas - MSN

Jul 12, 2025
pulisher
Jul 03, 2025

Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns - Benzinga

Jul 03, 2025
pulisher
Jul 02, 2025

Beta Bionics, Inc. to Release Q2 2025 Financial Results on July 29, 2025 - Nasdaq

Jul 02, 2025
pulisher
Jul 02, 2025

Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire

Jul 02, 2025
pulisher
Jun 29, 2025

Beta Bionics, Inc. (NASDAQ:BBNX) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Jun 29, 2025
pulisher
Jun 26, 2025

Pump manufacturers: Patches are the fix for low AID uptake - BioWorld MedTech

Jun 26, 2025
pulisher
Jun 24, 2025

ADA takeaways: Diabetes tech firms preview new patch pumps, glucose sensors - MedTech Dive

Jun 24, 2025
pulisher
Jun 23, 2025

BBNX Stock May Gain From Abbott Deal to Advance iLet Integration - Zacks Investment Research

Jun 23, 2025
pulisher
Jun 23, 2025

Analysts expect Beta Bionics patch pump launch by 2027 - MassDevice

Jun 23, 2025
pulisher
Jun 20, 2025

5 things to watch at the ADA’s Scientific Sessions - MedTech Dive

Jun 20, 2025
pulisher
Jun 19, 2025

Beta Bionics Announces Agreement with Abbott to Integrate - GlobeNewswire

Jun 19, 2025
pulisher
Jun 18, 2025

Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight - GlobeNewswire Inc.

Jun 18, 2025
pulisher
Jun 17, 2025

Beta Bionics (NASDAQ:BBNX) Now Covered by Truist Financial - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Beta Bionics initiated with a Buy at Truist - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Beta Bionics, Inc.: Strategic Growth and Market Penetration with iLet Infusion Pump - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Beta Bionics stock initiated with Buy rating at Truist Securities By Investing.com - Investing.com South Africa

Jun 16, 2025
pulisher
Jun 16, 2025

Beta Bionics stock initiated with Buy rating at Truist Securities - Investing.com

Jun 16, 2025
pulisher
Jun 14, 2025

Lake Street Capital Initiates Coverage on Beta Bionics (NASDAQ:BBNX) - Defense World

Jun 14, 2025
pulisher
Jun 07, 2025

Beta Bionics, Inc. (NASDAQ:BBNX) Receives $23.13 Average Price Target from Brokerages - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

Beta Bionics Executives Unload Shares in Major Stock Sell-Off! - TipRanks

Jun 04, 2025
pulisher
Jun 02, 2025

Beta Bionics CEO, CFO on how to take a company public - MedTech Dive

Jun 02, 2025
pulisher
Jun 02, 2025

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Benzinga

Jun 02, 2025
pulisher
Jun 01, 2025

Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating - Insider Monkey

Jun 01, 2025
pulisher
May 31, 2025

Beta Bionics (NASDAQ:BBNX) Now Covered by The Goldman Sachs Group - Defense World

May 31, 2025
pulisher
May 31, 2025

Beta Bionics (NASDAQ:BBNX) Coverage Initiated by Analysts at Wolfe Research - Defense World

May 31, 2025

Finanzdaten der Beta Bionics Inc-Aktie (BBNX)

Es liegen keine Finanzdaten für Beta Bionics Inc (BBNX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$285.57
price up icon 1.64%
medical_devices STE
$223.69
price up icon 0.47%
medical_devices PHG
$25.02
price up icon 1.96%
$85.12
price up icon 1.30%
$76.49
price up icon 3.14%
medical_devices EW
$76.30
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):